258 related articles for article (PubMed ID: 27601344)
1. Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers.
Downey-Slinker ED; Ridpath JF; Sawyer JE; Skow LC; Herring AD
Vaccine; 2016 Sep; 34(42):5053-5059. PubMed ID: 27601344
[TBL] [Abstract][Full Text] [Related]
2. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
3. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
4. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
Xue W; Mattick D; Smith L; Maxwell J
Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
7. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
[TBL] [Abstract][Full Text] [Related]
8. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
9. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
[TBL] [Abstract][Full Text] [Related]
10. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
11. The Occurrence of a Commercial N
Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
Viruses; 2018 May; 10(5):. PubMed ID: 29783722
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
14. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
15. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
16. In vitro neutralization of HoBi-like viruses by antibodies in serum of cattle immunized with inactivated or modified live vaccines of bovine viral diarrhea viruses 1 and 2.
Bauermann FV; Harmon A; Flores EF; Falkenberg SM; Reecy JM; Ridpath JF
Vet Microbiol; 2013 Sep; 166(1-2):242-5. PubMed ID: 23764273
[TBL] [Abstract][Full Text] [Related]
17. Immune response and onset of protection from Bovine viral diarrhea virus 2 infection induced by modified-live virus vaccination concurrent with injectable trace minerals administration in newly received beef calves.
Bittar JHJ; Palomares RA; Hurley DJ; Hoyos-Jaramillo A; Rodriguez A; Stoskute A; Hamrick B; Norton N; Adkins M; Saliki JT; Sanchez S; Lauber K
Vet Immunol Immunopathol; 2020 Jul; 225():110055. PubMed ID: 32438245
[TBL] [Abstract][Full Text] [Related]
18. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
[TBL] [Abstract][Full Text] [Related]
19. Maternal antibody blocks humoral but not T cell responses to BVDV.
Endsley JJ; Roth JA; Ridpath J; Neill J
Biologicals; 2003 Jun; 31(2):123-5. PubMed ID: 12770543
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]